Polpharma Pharmaceutical Works - API Manufacturer

drukuj

Current API product portfolio   

Ethenzamide

Specification:
  • in-house
chemical name: 2-Ethoxybenzamide, o-Ethylsalicylamide
molecular formula: C9H11NO2
structural formula: structural formula
molecular weight: 165.09
CAS Registery number: 938-73-8

General information:

Appearance: a white to cream-white, odourless, powder.
Solubility: soluble in ethanol and in methanol, practically insoluble in water and in solutions of alkali hydroxides.

TESTS REQUIERMENTS METHODS
Identification:

A. UV spectrum

B. IR spectrum


maximum at 293 nm ± 2 nm

comparison with reference substance spectrum
POLPHARMA
Melting range 129°C to 132°C Ph. Eur.
Chromatographic purity (HPLC):

- salicylamide

- salicylic acid

- any other impurity

- total impurities


not more than 0.2%

not more than 0.1%

not more than 0.1%

not more than 0.5%
POLPHARMA
Chlorides not more than 0.0175% POLPHARMA
Heavy metals not more than 0.001% Ph. Eur.
Readily carbonizable substances colour is not more intensive than reference solution POLPHARMA
Loss on drying not more than 0.5% POLPHARMA
Sulphated ash not more than 0.1% Ph. Eur.
Content of ethenzamide calculated on the dried substance 98.0% to 101.5% POLPHARMA
Residual solvents:

- methanol


not more than 1500 ppm
POLPHARMA
« back to API list

Latest news

CEP for Baclofen available

Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...

Polpharma – the most innovative company in Poland

Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...

Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex

Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...

Co-operation between Polpharma and RPG Life Sciences

Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...
© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo